DAFNA Capital Management’s UroGen Pharma URGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-27,515	Closed	-$549K	–	87
2025 Q3	$549K	Sell	27,515 -322,000	-92%	-$5.78M	0.14%	67
2025 Q2	$4.79M	Sell	349,515 -143,000	-29%	-$1.37M	1.32%	23
2025 Q1	$5.45M	Hold	492,515	–	–	1.54%	18
2024 Q4	$5.25M	Buy	492,515 +33,600	+7%	+$402K	1.33%	19
2024 Q3	$5.83M	Sell	458,915 -10,085	-2%	-$150K	1.38%	22
2024 Q2	$7.87M	Buy	+469,000	New	+$6.67M	1.88%	20
2020 Q2	–	Sell	-2,369	Closed	-$42K	–	92
2020 Q1	$42K	Sell	2,369 -1,618	-41%	-$43.7K	0.02%	80
2019 Q4	$133K	Sell	3,987 -11,013	-73%	-$301K	0.05%	79
2019 Q3	$357K	Hold	15,000	–	–	0.13%	77
2019 Q2	$539K	Hold	15,000	–	–	0.2%	69
2019 Q1	$554K	Hold	15,000	–	–	0.24%	65
2018 Q4	$646K	Hold	15,000	–	–	0.32%	55
2018 Q3	$708K	Buy	15,000 +5,000	+50%	+$232K	0.29%	57
2018 Q2	$498K	Buy	10,000 +5,500	+122%	+$320K	0.23%	61
2018 Q1	$224K	Buy	+4,500	New	+$225K	0.11%	68